Outsourcing Pharma January 24, 2024 Read the full article >> Why do you think it is important to attend SCOPE? With uncertainties in the economy, growing pressures to reduce the cost of treatments, and at the same time delivering on the promise of personalized medicine, pharma is at a critical crossroads in how they approach[…]
Healthcare IT Today January 15, 2024 Read the full article >> Joseph Zabinski, Ph.D., Managing Director, AI & Personalized Medicine at OM1 The Anti-Prediction of AI in 2024: The healthcare industry likes to compare artificial intelligence (AI) to a standard of perfection – we want it to get the answer ‘right’ every time, and sometimes, we’ll[…]
Pharma’s Almanac December 15, 2023 Read the full article >> Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1 I believe increased focus and pressure to ensure diversity and inclusiveness in clinical trials will be a key mechanism to drive multiple areas of important advancements. Improved diversity in trials has been a topic for decades but until[…]
Pharma’s Almanac December, 14, 2024 Read the full article >> Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1 The omnipresent dynamic of 2023 has been the decline in COVID, with patients, providers, and the pharma/biopharma industry adjusting to the aftermath of the pandemic. COVID-related deaths continue to fall, currently reaching levels seen in the very early days of[…]
Dermatology Times December 15, 2023 Stefan Weiss, MD, MBA, FAAD Read the full article >> 2023 brought exciting advances in the treatment of alopecia areata and vitiligo, autoimmune skin conditions that can significantly impact a person’s physical appearance and emotional well-being. The emergence of Janus kinase (JAK) inhibitors has shown tremendous promise as a novel[…]
